The Story of Influenza Antivirals: Part 12

The night before: 25 September 2010

My tabulation of the TOC comments on Relenza/Zanamivir had occupied my week preceding the meeting. What I found was interesting, surprising, and in some cases shocking. I decided to focus everyone's attention at the Oxford meeting by presenting some of the relevant extracts from the Medical Officer Review and the Statistical Officer Reviews as part of t…